Advantar Adds Executive Superhero


Advantar Laboratories, Inc. recently announced the addition of Dave Bergstrom, PhD, to the company’s executive team as Chief Operating Officer. Dr. Bergstrom will be responsible for managing overall business operations, including laboratory maintenance, project management, facilities planning, and human resources.

“Dr. Bergstrom brings to our team an invaluable amount of experience in drug development across the commercial and contract sides of our Industry” said Rich Kenley, PhD, CEO of Advantar Laboratories, Inc. “We’re looking forward to his leadership and contributions that will translate to increased customer value and even more efficient laboratory operations, thus strengthening our ability to continue empowering drug development.”

“Advantar has demonstrated strong growth since opening its doors in 2009, and their recent lab expansion is a testament to their overall experience and ability to formulate with the right ingredients for success. I look forward to ensuring we have the right tools, teams, and systems in place that will allow for scaling of existing service offerings and the seamless integration of new ones in the future,” said Dr. Bergstrom.

Dr. Bergstrom comes to Advantar from NovaDel Pharmaceuticals, Inc., where he joined in 2006 as Senior Vice President and Chief Operating Officer. He previously served as Senior Vice President and General Manager of the Pharmaceutical Development business of Cardinal Health, Inc. Prior to Cardinal Health, Dr. Bergstrom served as Vice President of Pharmaceutical and Chemical Development at Guilford Pharmaceuticals and also served in senior positions in preclinical development and pharmaceutical and analytical development at Hoechst-Roussel Pharmaceuticals, Inc., predecessor companies of Sanofi-Aventis Pharmaceuticals, Inc.

San Diego, CA-based Advantar Laboratories, Inc. is a top-tier contract testing laboratory specializing in Routine QC & Monograph Testing, Methods Development/Validation, Pre-formulation, and Formulation Development, QA Consulting, Clinical Packaging/Kitting and ICH Stability Studies for small and large molecule programs ranging in phase from Pre-clinical through to Clinical and Commercial. For more information, visit www.advantarlabs.com or contact Brandon Griffin at (858) 228-7788.